Mohr Davidow Ventures (MDV) is a leading Silicon Valley-based venture capital firm that for 25 years has identified, mentored, and developed entrepreneurs and young companies redefining business, technology, and medicine. The firm partners with entrepreneurs and takes a hands-on approach to architect and help build successful companies. MDV’s team and extended network of industry experts bring years of real-world experience to accelerate each company’s time to market and optimize its long term success. Category-leading companies funded by MDV include: Agile (ORCL), Brocade (BRCD), Energy Innovations, Epigram (BRCM), FormFactor (FORM), hi5, Ipsilon Networks(NOK), Kaplana (CSCO), Nanosolar, ONI Systems (CIEN), ParAllele (AFFX), Pivitol Technologies(BRCM), and Shutterfly (SFLY). MDV has $2 billion dollars under management.
		Alloy Ventures invests primarily in seed and early stage companies in information technology and the life sciences. The firm's total committed capital under management exceeds $1 billion, including $368 million committed to Alloy Ventures in 2005. The firm's partners have been founders and CEOs of successful start-ups, officers of large companies, and have decades of venture capital experience. The firm offers entrepreneurs the experience, connections and capital necessary to build lasting, market-leading companies.
		Draper Fisher Jurvetson is the preeminent venture capital firm with global presence through a network of partner funds, with offices in more than 30 cities around the world and over $6 billion in capital commitments. DFJ's mission is to identify, serve, and provide capital for extraordinary entrepreneurs anywhere who are determined to change the world. Over the past twenty years, DFJ has been proud to back more than 300 companies across many sectors including such industry-changing catalysts as Hotmail (acquired by MSFT), Baidu (BIDU), Skype (acquired by EBAY), Parametric (PMTC), United Online (UNTD), and Overture (acquired by YHOO). In 2001, DFJ became one of the early champions of Clean Technology, pioneering investments in solar, energy efficiency, advanced fuels, transportation, clean coal and a host of other areas. With climate change and dependence on foreign oil at the forefront of public consciousness, there has never been a more important time to be catalyzing clean technologies, and with 30 investments in the sector including winners such as EnerNoc (ENOC), DFJ has built a depth of expertise and experience that makes it one of the foremost early stage investors in the space.
		Iceland Genomic Ventures (IGV) is a privately held seed stage investment group that is financed by local angel and institutional investors and is based in Reykjavic, Iceland. In late 2000 IGV had the foresight to become the initial investor in Genomatica providing the full Series A financing for Genomatica.
		TPG Biotech is part of the growth equity and venture investment platform of TPG, the global private investment firm. With more than $1 billion under management, TPG Biotech targets investments in life science, biotechnology, renewables, medical technology, diagnostics, and services companies. TPG Biotech has access to the broader resources of TPG. Please visit www.tpgbiotech.com